Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy
Acupressure for Anxiety: A Pilot Study of a Nurse-Led Acupressure Intervention for Patients Receiving Chemotherapy
3 other identifiers
interventional
30
1 country
1
Brief Summary
This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicinal ways to manage symptoms. Acupressure is a noninvasive intervention that can be used for many different symptoms. Acupressure is well tolerated with minimal reports of adverse reactions, making it a good choice for patients with cancer. This study may help researchers learn whether acupressure is useful for managing anxiety in patients undergoing chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 14, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedOctober 29, 2025
October 1, 2025
6 months
March 14, 2024
October 27, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Number of patients approached about undergoing acupressure intervention (Feasibility)
Assessed by the number of patients approached about undergoing acupressure intervention.
Up to 1 year
Number of patients interested in the initial acupressure intervention in the chemotherapy unit (Feasibility)
Assessed by the number of patients who express interest in the initial acupressure intervention in the chemotherapy unit.
Up to 1 year
Number of patients interested in the home acupressure intervention (Feasibility)
Assessed by the number of patients who express interest in the home acupressure intervention.
Up to 1 year
Time taken for each nurse-led acupressure intervention in the chemotherapy unit (Feasibility)
Assess by the time recorded for ach nurse-led acupressure intervention in the chemotherapy unit.
Up to 1 year
Patient-reported changes in acute anxiety
Assessed with a brief anxiety questionnaire that inquires about the three different domains of anxiety: cognitive symptoms, emotional symptoms, and physical symptoms. Seven questions are answered using 11-point (0-10) scales with different values assigned to the scale per question (e.g. 0=no anxiety/10=worst possible anxiety or 0=strongly disagree/10=strongly agree).
At baseline, after a one-time nurse-administered acupressure session, and after one week of self-administered acupressure sessions
Study Arms (1)
Supportive Care (acupressure)
EXPERIMENTALPatients undergo acupressure over 15-120 seconds at a time for up to 15 minutes. After completion of the session, patients may optionally receive an education session on using acupressure at home.
Interventions
Undergo acupressure
Receive education session about using acupressure at home
Eligibility Criteria
You may qualify if:
- Be over 18 years of age
- Be actively undergoing chemotherapy in the Mayo Clinic chemotherapy unit
- Report anxiety as a 1 or higher, on a scale from 0 (no anxiety) to 4 (severe anxiety)
- Be willing to undergo a short acupressure session
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura S. Rhee, D.O.
Mayo Clinic in Rochester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2024
First Posted
March 21, 2024
Study Start
August 8, 2023
Primary Completion
January 29, 2024
Study Completion
February 1, 2024
Last Updated
October 29, 2025
Record last verified: 2025-10